Rate My Professor Stacie Dusetzina

Dusetzina's research at UNC Chapel Hill investigated drug utilization patterns, racial disparities in cancer supportive care, industry influences on treatment guidelines, and policy effects on medication adherence, including studies on Affordable Care Act impacts and chemotherapy-induced nausea management. Notable publications include 'Drug pricing trends for orally-administered anticancer medications reimbursed by commercial health plans, 2000-2014' (JAMA Oncology, 2016), 'Financial relationships with industry among National Comprehensive Cancer Network guideline authors' (JAMA Oncology, 2016), and 'Examining Racial Variation in Antiemetic Use and Post-Chemotherapy Health Care Utilization for Nausea and Vomiting Among Breast Cancer Patients' (Supportive Care in Cancer, 2016). She contributed to the President's Cancer Panel workshops on cancer drug pricing in 2016 and 2017 and served on the National Academies of Sciences, Engineering, and Medicine committee on ensuring patient access to affordable drugs. In 2018, she joined Vanderbilt University School of Medicine as Associate Professor of Health Policy, becoming Professor and Ingram Professor of Cancer Research in 2022. Her ongoing work examines Medicare drug spending, financial toxicity in oncology, and policy reforms like the Inflation Reduction Act, with over 10,000 Google Scholar citations influencing national debates on drug affordability. Awards include Best Abstract in Category at the American Society of Clinical Oncology Annual Meeting (2018) and appointment as Commissioner on the Medicare Payment Advisory Commission since 2021. She serves on the ICER Midwest Comparative Effectiveness Public Advisory Council and NCI PDQ Adult Treatment Editorial Board on Financial Toxicity & Cancer.